Color discrimination performance in patients with alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 27, Issue 6, 2009, Pages 501-507

  Salamone, Giovanna ^a   Di Lorenzo, Concetta ^a   Mosti, Serena ^a   Lupo, Federica ^a   Cravello, Luca ^a   Palmer, Katie ^a   Musicco, Massimo ^a,c   Caltagirone, Carlo ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c CNR   (Italy)

Author keywords

Alzheimer's disease; Cognitive impairment; Color discrimination; Perceptive sensory disturbance

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; COLOR DISCRIMINATION; COLOR VISION DEFECT; COLOR VISION TEST; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; TASK PERFORMANCE;

AGED; ALZHEIMER DISEASE; ATTENTION; COLOR PERCEPTION; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; DISCRIMINATION (PSYCHOLOGY); FEMALE; HUMANS; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE;

EID: 65649153798     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218366     Document Type: Article

References (33)

1. Perry RJ, Watson P, Hodges JR: The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: relationship to episodic and semantic memory impairment. Neuropsychologia 2000; 38: 252-271.
2. Sadun AA, Bassi CJ: The visual system in Alzheimer's disease. Res Publ Assoc Res Nerv Ment Dis 1990; 67: 331-347.
3. Holroyd S, Shepherd ML: Alzheimer's disease: a review for the ophthalmologist. Surv Ophthalmol 2001; 45: 516-524.
4. Hendry SH, Hsiao SS, Brown MC: Fundamentals of sensory systems; in Squire LR, McConnell SK, Roberts JL, Zigmond MJ, Spitzer NC (eds): Fundamental Neuroscience. San Diego, Ca., Academic Press, 2002, pp 577-589.
5. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW: The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1991; 1: 103-116.
6. Ikonomovic MD, Mufson EJ, Wuu J, Bennett DA, DeKosky ST: Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease. Arch Neurol 2005; 62: 425-430.
7. Dmitrieva NA, Strang CE, Keyser KT: Expression of alpha 7 nicotinic acetylcholine receptors by bipolar, amacrine, and ganglion cells of the rabbit retina. J Histochem Cytochem 2007; 55: 461-476.
8. Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL: Retinal abnormalities in early Alzheimer's disease. Invest Ophthalmol Vis Sci 2007; 48: 2285-2289.
9. Blanks JC, Schmidt SY, Torigoe Y, Porrello KV, Hinton DR, Blanks RH: Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging 1996; 17: 385-395.
10. Blanks JC, Torigoe Y, Hinton DR, Blanks RH: Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging 1996; 17: 377-384.
11. Iseri PK, Altinas O, Tokay T, Yuksel N: Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 2006; 26: 18-24.
12. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
13. Folstein MF, Folstein SE, McHugh PR: 'Minimental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
14. Farnsworth D: The Farnsworth-Munsell 100-HUE Test. Baltimore, Munsell Color Company, 1957.
15. Kinnear PR, Sahraie A: New Farnsworth-Munsell 100 hue test norms of normal observers for each year of age 5-22 and for age decades 30-70. Br J Ophthalmol 2002;86: 1408-1411.
16. Rey A: L'examen psychologique dans les case d'encéphalopathie traumatique. Arch Psychol 1941; 28: 286-340.
17. Rey A: Mémorisation d'une série de 15 mots en 5 répétition. Paris, Presses Universitaires de France, 1958.
18. Rey A: Reattivo della figura complessa: manuale. Firenze, Organizzazioni Speciali, 1983.
19. Carlesimo GA, Caltagirone C, Gainotti G: The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 1996; 36: 378-384.
20. Carlesimo GA, Buccione I, Fadda L, Graceffa A, Manni M, Lo Russo S: Standardizzazione di due test di memoria per uso clinico: Breve Racconto e Figura di Rey. Nuova Riv Neurol 2002; 12: 3-13.
21. Orsini A, Grossi D, Capitani E, Laiacona M, Papagno C, Vallar G: Verbal and spatial immediate memory span: normative data from 1355 adults and 1112 children. Ital J Neurol Sci 1987; 8: 539-548.
22. Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E: Trail making test: normative values from 287 normal adult controls. Ital J Neurol Sci 1996; 17: 305-309.
23. Nocentini U, Di Vincenzo S, Panella M, Pasqualetti P, Caltagirone C: La valutazione delle funzioni esecutive nella pratica neuropsicologica: dal Modified Card Sorting Test al Modified Card Sorting Test-Roma Version. Dati di standardizzazione. Neurologia 2002; 12: 14-24.
24. Spinnler H, Tognoni G: Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci 1987; 8(suppl 6):1-20.26 Cronin-Golomb A, Sugiura R, Corkin S, Growdon JH: Incomplete achromatopsia in Alzheimer's disease. Neurobiol Aging 1993; 14: 471-477.
25. Wijk H, Berg S, Bergman B, Hanson AB, Sivik L, Steen B: Colour perception among the very elderly related to visiual and cognitive function. Scand J Caring Sci 2002; 16: 91-102.
26. Cronin-Golomb A, Sugiura R, Corkin S, Growdon JH: Incomplete achromatopsia in Alzheimer's disease. Neurobiol Aging 1993; 14: 471-477.
27. Pache M, Smeets CH, Gasio PF, Savaskan E, Flammer J, Wirz-Justice A, Kaiser HJ: Colour vision deficiencies in Alzheimer's disease. Age Ageing 2003; 32: 422-426.
28. Katz B, Rimmer S, Iragui V, Katzman R: Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration? Ann Neurol 1989; 26: 221-225.
29. Sadun AA, Borchert M, DeVita E, Hinton DR, Bassi CJ: Assessment of visual impairment in patients with Alzheimer's disease. Am J Ophthalmol 1987; 104: 113-120.
30. Beelke M, Sannita WG: Cholinergic function and dysfunction in the visual system. Methods Find Exp Clin Pharmacol 2002; 24(suppl D):113-117.
31. Polyanskii VB, Evtikhin DV, Sokolov EN, Alymkulov DE: Computation of color and brightness differences by neurons in the lateral geniculate nucleus of the rabbit. Neurosci Behav Physiol 2007; 37: 237-247.
32. Mäntyjärvi M, Teräsvirta M: Observations on color vision testing in ocular hypertension and glaucoma. Int Ophthalmol 1992; 16: 417-422.
33. Quigley HA, Addicks EM, Green WR: Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol 1982; 100: 135-146.